Agenesis of the corpus callosum and gray matter heterotopia in three patients with constitutional mismatch repair deficiency syndrome.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9302235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5438 (Electronic) Linking ISSN: 10184813 NLM ISO Abbreviation: Eur J Hum Genet Subsets: MEDLINE

Publication: <2003->: London : Nature Publishing Group
Original Publication: Basel ; New York : Karger, [1992-

Agenesis of Corpus Callosum/*genetics ; DNA Repair-Deficiency Disorders/*genetics ; Glioblastoma/*complications ; Malformations of Cortical Development, Group II/*pathology ; Parotid Neoplasms/*complications; Adaptor Proteins, Signal Transducing/genetics ; Adenosine Triphosphatases/genetics ; Agenesis of Corpus Callosum/pathology ; Child ; Child, Preschool ; Contractile Proteins/genetics ; DNA Repair Enzymes/genetics ; DNA Repair-Deficiency Disorders/etiology ; DNA-Binding Proteins/genetics ; Female ; Filamins ; Glioblastoma/diagnosis ; Glioblastoma/genetics ; Glioblastoma/therapy ; Humans ; Male ; Malformations of Cortical Development, Group II/genetics ; Microfilament Proteins/genetics ; Microsatellite Instability ; Mismatch Repair Endonuclease PMS2 ; MutL Protein Homolog 1 ; Mutation ; Nuclear Proteins/genetics ; Parotid Neoplasms/diagnosis ; Parotid Neoplasms/genetics ; Parotid Neoplasms/therapy ; Pregnancy ; Syndrome

Constitutional mismatch repair deficiency (CMMR-D) syndrome is a rare inherited childhood cancer predisposition caused by biallelic germline mutations in one of the four mismatch repair (MMR)-genes, MLH1, MSH2, MSH6 or PMS2. Owing to a wide tumor spectrum, the lack of specific clinical features and the overlap with other cancer predisposing syndromes, diagnosis of CMMR-D is often delayed in pediatric cancer patients. Here, we report of three new CMMR-D patients all of whom developed more than one malignancy. The common finding in these three patients is agenesis of the corpus callosum (ACC). Gray matter heterotopia is present in two patients. One of the 57 previously reported CMMR-D patients with brain tumors (therefore all likely had cerebral imaging) also had ACC. With the present report the prevalence of cerebral malformations is at least 4/60 (6.6%). This number is well above the population birth prevalence of 0.09-0.36 live births with these cerebral malformations, suggesting that ACC and heterotopia are features of CMMR-D. Therefore, the presence of cerebral malformations in pediatric cancer patients should alert to the possible diagnosis of CMMR-D. ACC and gray matter heterotopia are the first congenital malformations described to occur at higher frequency in CMMR-D patients than in the general population. Further systematic evaluations of CMMR-D patients are needed to identify possible other malformations associated with this syndrome.

J Immunol. 2012 Feb 15;188(4):2023-9. (PMID: 22250089)
Eur J Hum Genet. 2007 Nov;15(11):1105-14. (PMID: 17637806)
Hum Mutat. 2008 Jun;29(6):852-60. (PMID: 18383312)
Am J Gastroenterol. 2010 Nov;105(11):2449-56. (PMID: 20531397)
Nat Genet. 2003 Apr;33(4):487-91. (PMID: 12612583)
Pediatr Blood Cancer. 2012 Oct;59(4):652-6. (PMID: 22180144)
Cancer Res. 1999 Jan 15;59(2):294-7. (PMID: 9927034)
Nat Rev Mol Cell Biol. 2006 May;7(5):335-46. (PMID: 16612326)
Genome Res. 2005 Jul;15(7):978-86. (PMID: 15965030)
Hum Mutat. 2011 Jan;32(1):107-15. (PMID: 21120944)
Gastroenterology. 2006 Feb;130(2):312-22. (PMID: 16472587)
Blood. 2004 Apr 1;103(7):2554-9. (PMID: 14670928)
Clin Genet. 2011 Sep;80(3):243-55. (PMID: 21261604)
Cancer Res. 1999 Jan 15;59(2):290-3. (PMID: 9927033)
Hum Mutat. 2010 May;31(5):552-60. (PMID: 20186689)
AJR Am J Roentgenol. 2006 Nov;187(5):1343-8. (PMID: 17056927)
J Med Genet. 2007 Jan;44(1):1-9. (PMID: 16825431)
Hum Mutat. 2007 Nov;28(11):1084-90. (PMID: 17557300)
Genes Chromosomes Cancer. 2002 Feb;33(2):160-7. (PMID: 11793442)
Clin Genet. 2011 Dec;80(6):558-65. (PMID: 21204794)
Neuroradiology. 2004 May;46(5):368-73. (PMID: 15103432)
Neuro Oncol. 2008 Feb;10(1):93-7. (PMID: 17993636)
J Med Genet. 2005 Feb;42(2):147-51. (PMID: 15689453)
Brain. 2006 Jul;129(Pt 7):1892-906. (PMID: 16684786)
Clin Genet. 2004 Oct;66(4):276-89. (PMID: 15355427)
Hum Mutat. 2008 Feb;29(2):299-305. (PMID: 18030674)
J Natl Cancer Inst. 2004 Feb 18;96(4):261-8. (PMID: 14970275)
Hum Genet. 2003 Feb;112(2):117-23. (PMID: 12522551)
Haematologica. 2010 May;95(5):841-4. (PMID: 20015892)
Pediatr Dev Pathol. 1998 Jan-Feb;1(1):42-8. (PMID: 10463270)
Hum Genet. 2008 Sep;124(2):105-22. (PMID: 18709565)
Epilepsy Behav. 2005 Sep;7(2):143-9. (PMID: 15996530)
Genome Res. 2001 May;11(5):863-74. (PMID: 11337480)
Hum Mutat. 2010 May;31(5):578-87. (PMID: 20186688)
J Exp Med. 2008 Oct 27;205(11):2465-72. (PMID: 18824584)
Nat Methods. 2010 Apr;7(4):248-9. (PMID: 20354512)
Nat Rev Neurosci. 2007 Apr;8(4):287-99. (PMID: 17375041)
Eur J Cancer. 2011 May;47(7):965-82. (PMID: 21376568)
Hum Mutat. 2011 Sep;32(9):1063-71. (PMID: 21618646)
Mutat Res. 2008 Jan 1;637(1-2):209-14. (PMID: 17889038)
Br J Cancer. 2010 Mar 16;102(6):1068-73. (PMID: 20160730)
Haematologica. 2010 May;95(5):699-701. (PMID: 20442441)
Clin Invest Med. 2005 Oct;28(5):267-82. (PMID: 16265999)
Genes Chromosomes Cancer. 2012 Sep;51(9):819-31. (PMID: 22585707)

0 (Adaptor Proteins, Signal Transducing)
0 (Contractile Proteins)
0 (DNA-Binding Proteins)
0 (Filamins)
0 (MLH1 protein, human)
0 (Microfilament Proteins)
0 (Nuclear Proteins)
EC 3.6.1.- (Adenosine Triphosphatases)
EC 3.6.1.- (PMS2 protein, human)
EC 3.6.1.3 (Mismatch Repair Endonuclease PMS2)
EC 3.6.1.3 (MutL Protein Homolog 1)
EC 6.5.1.- (DNA Repair Enzymes)

Date Created: 20120614 Date Completed: 20130520 Latest Revision: 20211021

20240829

PMC3522206

10.1038/ejhg.2012.117

22692065